article thumbnail

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 133
article thumbnail

Medxtractor Doubles Down on B2B Licensing & mHealth

Cannabis Law Report

(CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Using machine learning algorithms and qualified practitioner input, the company is leveraging that data to build tools that deliver digital diagnostic opinions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

Cannabis Law Report

The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021. Alzheimer’s disease impacts about 50 million people worldwide and about 5.5 million individuals in the U.S.

article thumbnail

Criminal Intelligence Analyst 0507 (Marijuana Enforcement Division) Bureau of Narcotics and Dangerous Drugs Control Oklahoma

Cannabis Law Report

Major Work Duties : Following are some of the major job duties: Conducts technical analysis and evaluations of intelligence data or criminal activity. Maintains cross reference files of criminal and case information. Liaison with private sector agencies and employees to facilitate the exchange of information.

Data 98
article thumbnail

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. Food and Drug Administration (FDA) on December 1, 2021.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

article thumbnail

Validating Hop Latent Viroid Assays the Right Way

Medicinal Genomics

Manufacturers generate validation data to demonstrate their test can detect the target molecule/organism with high sensitivity and specificity. There are also no industry standards and no certified reference material for HLVd, leaving manufacturers to set and source their own standards. coli , and pathogenic Aspergillus).

Data 52